HSP90AA1 and breast cancer: In another study, a nomogram model constructed by database and clinical parameter analyses to evaluate the prognosis and metastasis risk of breast cancer revealed pretreatment plasma HSP90AA1 combined with other biomarkers to easily predict the risk of breast cancer incidence and metastasis (Liu et al. 2021).